Protocol No.: S1900K

A Randomized Phase II Study of Tepotinib with or without Ramucirumab in Participants with MET Exon 14 Skipping Positive Stage IV or Recurrent Non-small Cell Lung Cancer (Lung-Map Sub-Study)
Principal Investigator
Bhasin, Pooja Gogia
Phase
II (Cancer Control)
Age Group
Adult
Applicable Disease Site
Lung Cancer
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Rachel Harper
Clinical Research Specialist
Phone: +1 304-293-6066

View on ClinicalTrials.gov